Hello, and welcome to the 908 Devices Second Quarter 2024 Financial Results Conference Call. My name is Elliot, and I'll be the operator for your call today. [Operator Instructions] I would now like ...
Revenue: $14 million for Q3 2025, down 4% year over year. Revenue from Continuing Operations (YTD): $38.8 million, up 16% year over year. Recurring Revenue: 36% of total revenue, with a 10% increase ...
BOSTON, August 04, 2025--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Dr. Brandi Vann to serve ...
Except as required by law, 908 Devices disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future ...
BOSTON--(BUSINESS WIRE)--908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced the release of MX908™, a second-generation handheld chemical detection and ...
BOSTON--(BUSINESS WIRE)-- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced that it has expanded access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results